Drug intelligence / Profile preview

Astem-101

Development stage
Unknown
Lead developer
Angsheng Biomedical Technology
Modality
Cell Therapies
Administration
Injection
01

Overview

Astem-101 is an investigational cell therapy consisting of Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) delivered via injection. It is being developed by Shanghai Angsheng Biomedical Technology Co.,LTD for the treatment of Moderate to Severe Erectile Dysfunction (ED) associated with Type 2 Diabetes Mellitus. The therapy is currently in Phase 2 clinical trials, with an optimal dose level selected based on Phase 1 study results.

Other names
Astem-101 hUC-MSCAstem101 hUC-MSCAstem 101 hUC-MSCAstem-101 hUC-MSCsAstem101 hUC-MSCsAstem 101 hUC-MSCsAstem-101 human umbilical cord mesenchymal stem cell injectionAstem101 human umbilical cord mesenchymal stem cell injectionAstem 101 human umbilical cord mesenchymal stem cell injectionAstem-101 human umbilical cord mesenchymal stem cellsAstem101 human umbilical cord mesenchymal stem cellsAstem 101 human umbilical cord mesenchymal stem cellsAstem-101人脐带间充质干细胞Astem-101人脐带间充质干细胞注射液

Beyond the preview

Go deeper on Astem-101.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astem-101.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call